Study guide

5.3 Client Resources, Appropriateness & Timely Delivery

Certified Genetic Counselor CGC

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the CGC Exam & Credential 1.2 Eligibility Categories, Application & Fees 1.3 Scoring, Pass Rate & Test-Day Logistics

2 Domain 1A: Clinical Information

1.4 Medical & Pregnancy History 1.5 Teratogens, Exposures & Non-Genetic Risk Factors 1.6 Differential Diagnosis, Indication & Referral Urgency 1.7 Referral Triage, Case Preparation & Records Review

3 Domain 1B: Human Development

1.8 Fetal Development 1.9 Developmental Milestones 1.10 Physical & Psychological Development

4 Domain 1C: Chromosomal & Contiguous Gene Syndromes

1.11 Aneuploidy Syndromes (Down, Turner, Klinefelter, Edwards, Patau) 1.12 Microdeletion Syndromes (22q11.2, Williams, and Related) 1.13 Imprinting Disorders (PWS, Angelman, Beckwith-Wiedemann, Russell-Silver)

5 Domain 1C: Hereditary Cancer Syndromes

1.14 Hereditary Breast & Ovarian Cancer (BRCA1/2, PALB2, and Related) 1.15 Lynch Syndrome & Polyposis Syndromes 1.16 Li-Fraumeni, VHL, MEN, NF1/NF2 & Other Cancer Predisposition

6 Domain 1C: Metabolic, Neuromuscular & Multisystem Conditions

1.17 Inborn Errors of Metabolism & Storage Disorders 1.18 Neuromuscular Disease & Fragile X Spectrum 1.19 Connective Tissue & Cardiovascular Genetics 1.20 Screening, Surveillance, Treatment & Diagnostic Strategy Framework

7 Domain 2A: Pedigree & Risk Assessment

2.1 Family History, Pedigree Construction & Analysis 2.2 Mendelian Risk Calculations 2.3 Bayesian Risk Calculations 2.4 Empiric Risk, Multifactorial Recurrence & Risk-Assessment Models 2.5 Residual Risk & Follow-Up Medical Plans

8 Domain 2B: Inheritance Principles

2.6 Mendelian Inheritance Patterns 2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial) 2.8 Penetrance, Expressivity, Anticipation & Heterogeneity 2.9 Mosaicism, X-Inactivation & Epigenetic Modifiers of Phenotype

9 Domain 2B: Population Genetics & Variation

2.10 Population Genetics, HWE & Quantitative Genetics 2.11 Human Genetic Variation & Disease Susceptibility

10 Domain 3A: Test Methodologies

3.1 Karyotype, FISH & Chromosomal Microarray 3.2 Molecular Diagnostics (Sanger, NGS Panels, WES, WGS, MLPA) 3.3 Sample Types, Clinical Context & Predictive Metrics

11 Domain 3A: Variant Interpretation

3.4 ACMG/AMP Variant Classification 3.5 Reanalysis, Reclassification & Validity/Utility Framework

12 Domain 3B: Testing Options

3.6 Diagnostic Testing Strategies 3.7 Screening Testing (including Newborn Screening) 3.8 Predictive & Pre-symptomatic Testing 3.9 Carrier, Somatic & Research Testing

13 Domain 3C: Reproductive Risk Management

3.10 Assisted Reproductive Technologies & PGT 3.11 Family Planning & Reproductive Options 3.12 Prenatal Screening (NIPT, Serum Markers) 3.13 Prenatal Diagnostic Procedures (CVS, Amniocentesis)

14 Domain 4A: Counseling Foundations

4.1 Contracting & Interviewing Techniques 4.2 Psychosocial Assessment, Follow-Up & Family Dynamics 4.3 Client Personal Identity & Cultural Humility

15 Domain 4A: Theories, Coping & Dynamics

4.4 Counseling Theories & Models (REM, Trajectory) 4.5 Defense Mechanisms, Coping & Decision-Making Styles 4.6 Grief, Perinatal Loss & Crisis Response 4.7 Self-Awareness & Client-Counselor Dynamics

16 Domain 4B: Communication & Education

4.8 Delivery Modes & Working with Interpreters 4.9 Risk Communication Theories & Models 4.10 Results Delivery & Long-Term Follow-Up 4.11 Health Literacy, Informed Consent & Informed Decision Making

17 Domain 5A–B: Finance & Client Resources

5.1 Insurance Policies, Billing & Letters of Medical Necessity 5.2 Billing, Coding & Reimbursement Compliance 5.3 Client Resources, Appropriateness & Timely Delivery

18 Domain 5C: Legal & Regulatory Requirements

5.4 GINA & Genetic Non-Discrimination Legislation 5.5 Privacy, Confidentiality, Documentation & Genomic Data Security 5.6 Human-Subjects Research Standards & Patient Access to Information 5.7 CLIA, Laboratory-Developed Tests & FDA Oversight 5.8 Genomic Data Security, DTC Testing & Data Sharing

19 Domain 5D: Professional Frameworks

5.9 NSGC Code of Ethics & Ethical Decision Making 5.10 Scope of Practice, Clinical Supervision & Conflict of Interest 5.11 Licensure, Credentialing & Maintaining the CGC Credential 5.12 Evidence-Based Practice & Professional/Public Education

20 Integration & Exam Strategy

6.1 Integrating Domains in Case-Based Practice & Exam Strategy

5.3 Client Resources, Appropriateness & Timely Delivery

Key Takeaways Explain This Topic AI

Domain 5B expects genetic counselors to identify financial assistance and support resources—patient assistance programs, foundations, lab hardship policies—and match them to the client’s actual barriers.

Appropriateness means evaluating quality, eligibility, conflicts of interest, literacy/language fit, and whether a resource solves the problem (cost, transportation, peer support) without harmful delay.

Timely delivery differs by context: urgent pregnancy and treatment decisions need faster pathways than elective predictive testing that can wait for authorization or fundraising.

Resource counseling includes clear limits—eligibility is not approval—and avoids overpromising coverage, grant awards, or wait times.

Exam items often ask which resource or timing plan best fits the barrier, not which brochure sounds nicest.

Last updated: August 2026

Why client resources are a distinct scored subdomain

Subdomain 5B (8 scored) sits beside insurance/billing (5A) but asks a different question: once you know the barrier, which resources are appropriate , and how do you deliver them in time ? Genetic counselors routinely connect clients to financial aid, disease foundations, peer support, social work, transportation, interpreter services, and lab hardship programs. Doing this well is part of professional practice—not optional “nice extra” content.

On board vignettes, two answers may both offer “resources.” The better answer usually matches the barrier , checks eligibility/quality , and respects clinical timing (e.g., gestational age, surgery date, drug initiation).

Categories of resources GCs commonly use

Resource type Typical use Appropriateness checks

Manufacturer / lab patient assistance programs (PAPs) Reduce or cover test cost for uninsured/underinsured Income/residency rules; which tests included; data-sharing consents

Lab hardship / self-pay discounts Prompt-pay or sliding-scale pricing when PA denied or delayed Written quote; what is included (only sequencing? counseling?)

Nonprofit disease foundations Grants, travel funds, education, peer matching Legitimacy; application timelines vs clinical urgency

Hospital charity care / financial navigation Facility bills, facility-based counseling Application windows; documentation burden

Public programs Medicaid, CHIP, disability services, EI/school supports Eligibility vs assumption

Psychosocial supports Support groups, counseling referrals, crisis lines Evidence of quality; modality (in-person/online); cultural/language fit

  • Practical supports Transportation, childcare, lodging near specialty centers Solves the actual barrier to care
  • Patient assistance and foundation aid—how to talk about them

Frame accurately: “This program may help if you meet income and indication criteria; we can start the application, but approval is not guaranteed and processing takes time.” Collect only needed documents; do not shame clients for income questions. When labs offer hardship pricing, get a specific quote tied to the exact test and turnaround expectations.

Foundation grants can cover travel to a specialty clinic, lodging for infusion/gene-therapy evaluations, or genetic testing not covered by insurance. Watch application cycles—a quarterly grant does not help a client who needs CVS next week unless emergency funds exist.

Evaluating appropriateness and quality

Dumping a generic link list is not Domain 5B competence. Evaluate:

Fit to barrier — Cost problem → financial navigation/PAP; isolation → peer support; literacy → plain-language materials; language → qualified interpreters (process detail in Domain 4B).

Eligibility realism — Do not send undocumented clients only to programs that require citizenship if alternatives exist; do not promise foundation aid when the diagnosis is outside the foundation’s scope.

Quality and safety — Prefer established nonprofits, professional-society directories, and clinic-vetted groups. Be cautious with unmoderated forums that promote unproven treatments or scare-based content.

Conflicts and marketing — Some “assistance” funnels exclusively to one lab or product; disclose when a resource is industry-sponsored and discuss alternatives.

Health literacy and culture — Materials should match language and reading level; peer groups should not require clients to adopt a counselor’s values.

Privacy — PAPs and online groups may request sensitive data; review what will be shared.

Red flag Why it matters Better alternative

Guarantees of “free testing for everyone” Often bait-and-switch or narrow fine print Written eligibility criteria + quote

Pressure to join a specific clinical trial as the only “funding” May not match goals/eligibility Separate trial discussion from financial aid

Unverified GoFundMe as sole plan for urgent prenatal testing Unpredictable timing/amount Parallel self-pay quote + PA appeal + hospital aid

Referring to a group known for discriminatory or coercive advice Psychosocial harm Moderated, condition-specific reputable organizations

Timely delivery: urgency changes the playbook

Timeliness means the resource arrives before the decision window closes—not merely that you mentioned it someday.

Clinical context Timing pressure Resource strategy

Urgent pregnancy (diagnostic testing, time-sensitive decisions) Days–weeks matter Parallel paths: PA/appeal and self-pay/hardship quote; same-day financial navigation; avoid waiting solely on slow grants

Cancer treatment selection (e.g., therapy tied to germline/somatic results) Treatment deadlines Expedite PA, use lab STAT policies, hospital aid; document urgency in LMN

Elective predictive testing Often flexible Reasonable to wait for authorization, PAP approval, or budgeting

Cascade testing of relatives Variable Prioritize relatives whose results change immediate screening; batch outreach with clear cost options

  • Chronic rare disease support Ongoing Foundations, condition education, long-term financial planning
  • Urgent vs elective—exam discrimination

Urgent prenatal: Best answers often start dual tracks (insurance + transparent self-pay/hardship) and schedule follow-up before a gestational cutoff. Waiting passively for a foundation’s next board meeting is usually wrong.

Elective predictive: Best answers may defer the blood draw until funding/PA is resolved if delay does not create medical harm—especially when psychosocial readiness also favors waiting.

Do not equate urgency with coercing testing; urgency applies to resource logistics , while the testing decision remains the client’s.

Advocacy without overpromising

Resource advocacy scripts that boards reward:

“Here are programs that fit your situation; here is what each can and cannot do.”

“We will submit the assistance application today and set a check-in on Thursday so we are not waiting blindly.”

“If assistance is denied, we already have a self-pay maximum and a plan B.”

Scripts that fail:

  • “The foundation will definitely pay.”
  • “Don’t worry about cost at all.”
  • “This Facebook group will get your insurance to reverse the denial.”

Document what you offered, what the client chose, and timed follow-up. Coordinate with social work when barriers are multifactorial (housing, food insecurity, intimate partner violence) beyond genetics-specific aid.

Integrated scenarios

Scenario A — denied panel, elective cascade: Sibling of a BRCA pathogenic variant carrier is uninsured and not pregnant. Appropriate plan: lab hardship quote + PAP application + deferral of testing until funding is clear, plus psychosocial check-in—not pressure to put the test on a high-interest credit card today.

Scenario B — 16-week high-risk NIPT, underinsured: Appropriate plan: same-day benefits check, urgent PA/LMN if indicated, simultaneous self-pay diagnostic quote, and short-interval follow-up—not “apply to three foundations and call us next month.”

Scenario C — new rare-disease diagnosis: Parents ask for “any help.” Appropriate response: condition-specific reputable foundation for education/peer support plus hospital financial navigation for unpaid bills—not only a generic search-engine list, and not substituting peer anecdotes for medical follow-up.

Scenario D — industry-sponsored assistance: A PAP covers only one manufacturer’s panel. Discuss that limitation, compare clinically equivalent options, and let the client choose with eyes open.

Common traps

Offering resources that do not address the stated barrier (peer support when the need is a $3,000 bill).

Ignoring turnaround time of aid applications in time-sensitive pregnancies.

Overpromising grant approval or lab write-offs.

Referring to low-quality or coercive communities without vetting.

Treating resource referral as a one-time handoff with no follow-up plan.

Quick exam checklist

What exact barrier are we solving (cost, access, support, literacy)?

Is this resource eligible, reputable, and conflict-aware?

Does timing match urgency (pregnancy/treatment vs elective)?

Are we running parallel paths when delay is harmful?

Did we avoid guarantees and set a concrete follow-up?